![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Center for Disease Control. Genital herpes infection—United States, 1966–79. Morbidity and Mortality Weekly Report 1982; 31: 137–139
- Corey L., Holmes K. K. Genital herpes simplex virus infections: Current concepts in diagnosis, therapy and prevention. Annals of Internal Medicine 1983; 98: 973–983
- Nilsen A. E., Aasen T., Halsos A. M., Kinge B. R., Tjotta E. A., Wikström K., Fiddian A. P. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet 1982; ii: 571–573
- Stratton J. A., Miller R. D., Kent D. R., Thrupp L. D., Richards C., DiSaia P. J. Depressed mononuclear cell phagocytic activity associated with menstruation. Journal of Clinical and Laboratory Immunology 1984; 15: 127–131
- Strauss S. E., Takiff H. E., Seidlin M., Bachrach S., Lininger L., DiGiovanna J. J., Western K. A., Smith H. A., Lehrman S. N., Cregh‐Kirk T. Suppression of frequently recurring genital herpes. A placebo‐controlled double‐blind trial of oral acyclovir. New England Journal of Medicine 1984; 310: 1545–1550
- Wickett W. H., Bradshaw L., Wilson J., Glasky A. Clinical effectiveness of the immunopotentiating agent inosiplex in herpes infections. American Society for Microbiology, Atlantic City, N. J. 1976